Literature DB >> 19104025

Affinity of Tomopenem (CS-023) for penicillin-binding proteins in Staphylococcus aureus, Escherichia coli, and Pseudomonas aeruginosa.

Tetsufumi Koga1, Chika Sugihara, Masayo Kakuta, Nobuhisa Masuda, Eiko Namba, Takashi Fukuoka.   

Abstract

Tomopenem (formerly CS-023), a novel 1beta-methylcarbapenem, exhibited high affinity for penicillin-binding protein (PBP) 2 in Staphylococcus aureus, PBP 2 in Escherichia coli, and PBPs 2 and 3 in Pseudomonas aeruginosa, which are considered major lethal targets. Morphologically, tomopenem induced spherical forms in E. coli and short filamentation with bulges in P. aeruginosa, which correlated with the drug's PBP profiles. The potential of resistance of these bacteria to tomopenem was comparable to that to imipenem.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19104025      PMCID: PMC2650550          DOI: 10.1128/AAC.01433-08

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  14 in total

1.  BOCILLIN FL, a sensitive and commercially available reagent for detection of penicillin-binding proteins.

Authors:  G Zhao; T I Meier; S D Kahl; K R Gee; L C Blaszczak
Journal:  Antimicrob Agents Chemother       Date:  1999-05       Impact factor: 5.191

2.  Comparison of two carbapenems, SM-7338 and imipenem: affinities for penicillin-binding proteins and morphological changes.

Authors:  Y Sumita; M Fukasawa; T Okuda
Journal:  J Antibiot (Tokyo)       Date:  1990-03       Impact factor: 2.649

3.  In vitro and in vivo antibacterial activities of CS-023 (RO4908463), a novel parenteral carbapenem.

Authors:  Tetsufumi Koga; Tomomi Abe; Harumi Inoue; Takashi Takenouchi; Akiko Kitayama; Tatsuhiko Yoshida; Nobuhisa Masuda; Chika Sugihara; Masayo Kakuta; Miyuki Nakagawa; Takahiro Shibayama; Yoko Matsushita; Takashi Hirota; Satoshi Ohya; Yukio Utsui; Takashi Fukuoka; Syogo Kuwahara
Journal:  Antimicrob Agents Chemother       Date:  2005-08       Impact factor: 5.191

4.  Penicillin: its basic site of action as an inhibitor of a peptide cross-linking reaction in cell wall mucopeptide synthesis.

Authors:  E M Wise; J T Park
Journal:  Proc Natl Acad Sci U S A       Date:  1965-07       Impact factor: 11.205

5.  Distinct penicillin binding proteins involved in the division, elongation, and shape of Escherichia coli K12.

Authors:  B G Spratt
Journal:  Proc Natl Acad Sci U S A       Date:  1975-08       Impact factor: 11.205

6.  Imipenem resistance in clinical isolates of Proteus mirabilis associated with alterations in penicillin-binding proteins.

Authors:  C Neuwirth; E Siébor; J M Duez; A Péchinot; A Kazmierczak
Journal:  J Antimicrob Chemother       Date:  1995-08       Impact factor: 5.790

7.  Role of an altered penicillin-binding protein in methicillin- and cephem-resistant Staphylococcus aureus.

Authors:  Y Utsui; T Yokota
Journal:  Antimicrob Agents Chemother       Date:  1985-09       Impact factor: 5.191

8.  Potent in vitro activity of tomopenem (CS-023) against methicillin-resistant Staphylococcus aureus and Pseudomonas aeruginosa.

Authors:  Tetsufumi Koga; Nobuhisa Masuda; Masayo Kakuta; Eiko Namba; Chika Sugihara; Takashi Fukuoka
Journal:  Antimicrob Agents Chemother       Date:  2008-06-02       Impact factor: 5.191

9.  Consumption of imipenem correlates with beta-lactam resistance in Pseudomonas aeruginosa.

Authors:  Philipp M Lepper; Eberhard Grusa; Helga Reichl; Josef Högel; Matthias Trautmann
Journal:  Antimicrob Agents Chemother       Date:  2002-09       Impact factor: 5.191

10.  Cross-resistance to meropenem, cephems, and quinolones in Pseudomonas aeruginosa.

Authors:  N Masuda; S Ohya
Journal:  Antimicrob Agents Chemother       Date:  1992-09       Impact factor: 5.191

View more
  2 in total

Review 1.  Carbapenems: past, present, and future.

Authors:  Krisztina M Papp-Wallace; Andrea Endimiani; Magdalena A Taracila; Robert A Bonomo
Journal:  Antimicrob Agents Chemother       Date:  2011-08-22       Impact factor: 5.191

2.  Synergistic, collaterally sensitive β-lactam combinations suppress resistance in MRSA.

Authors:  Patrick R Gonzales; Mitchell W Pesesky; Renee Bouley; Anna Ballard; Brent A Biddy; Mark A Suckow; William R Wolter; Valerie A Schroeder; Carey-Ann D Burnham; Shahriar Mobashery; Mayland Chang; Gautam Dantas
Journal:  Nat Chem Biol       Date:  2015-09-14       Impact factor: 15.040

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.